Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SZSE: 300357)
Health Care · Pharmaceuticals · CN
CN¥19.99
-1.67% today · -30.7% 1Y
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SZSE: 300357) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.56B and employs 1,808 people.
Over the last twelve months the share price has lost 30.7%, trading between 18.65 and 35.84.
Tweenvest scores Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. across four factors: quality 86/100, value 79/100, growth 64/100, dividend 19/100. Its strongest factor is quality.
300357 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.56B
- Revenue (TTM)
- $160.81M
- P/E
- 25.08
- EPS
- 0.80
- Dividend yield
- 1.25%
- Beta (5Y)
- 0.42
- 52-week high
- CN¥35.84
- 52-week low
- CN¥18.65
- Avg volume (3M)
- —
- Shares outstanding
- 523.58M
- Employees
- 1,808
- Next earnings
- —
About Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. operates as a biopharmaceutical enterprise, primarily engaged in the discovery, development, production, and sale of medicinal products. The company's core focus is on pharmaceuticals designed for the diagnosis and management of allergic conditions, which it supplies to both the Chinese domestic market and international clientele. Additionally, its portfolio encompasses various skincare lines and stem cell-related solutions. The firm's main offices are located in Huzhou, China.
- ISIN
- CNE100001R58
- Founded
- 2002
- Listed since
- Jan 21, 2014
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| CSPC Hunan Jingfeng Pharmaceutical Co., Ltd.SZSE: 000908 | $1.58B | CN¥6.02 | +0.50% |
| Sopharma ADBUL: SFA | $1.58B | €2.62 | -0.38% |
| Eton Pharmaceuticals, Inc.NasdaqGM: ETON | $1.58B | $55.21 | +0.84% |
| Mezzion Pharma Co.,Ltd.KOSDAQ: A140410 | $1.57B | ₩69,000.00 | +1.47% |
| Square Pharmaceuticals PLC.DSE: SQURPHARMA | $1.56B | Tk217.10 | -0.55% |
| Phibro Animal Health CorporationNasdaqGM: PAHC | $1.56B | $38.30 | +2.41% |
| North China Pharmaceutical Company.LtdSHSE: 600812 | $1.54B | CN¥6.03 | +21.08% |
| Innoviva, Inc.NasdaqGS: INVA | $1.53B | $21.21 | +1.63% |
Figures last refreshed Oct 11, 2026.